BD executive sells 1,100 Becton Dickinson shares
Becton Dickinson & Co executive Michael David Garrison reported an open-market sale of company stock.
Rhea-AI Filing Summary
Becton Dickinson & Co executive Michael David Garrison reported an open-market sale of company stock. On June 10, 2026, he sold 1,100 shares of Common Stock at an average price of $151.48 per share. After this transaction, he directly holds 14,272 shares. A footnote explains that his direct holdings reflect prior adjustments tied to the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp., which affected the number of shares underlying previously reported, unvested time-vested restricted stock units.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,100 | $151.48 | $167K |
Footnotes (1)
- F1. Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person.
Key Figures
Key Terms
open-market sale financial
restricted stock units financial
Common Stock financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Becton Dickinson (BDX) report for Michael David Garrison?
What is Michael David Garrison’s role at Becton Dickinson (BDX)?
Was the Becton Dickinson (BDX) insider sale an open-market transaction?
What does the Waters Corp. footnote mean in the Becton Dickinson (BDX) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.